Fatigue and Sleep Disturbance Are Persistent Issues for Patients Undergoing TACE
Researchers explored the factors that influence sleep quality in patients with hepatocellular cancer undergoing TACE.
Conventional and Hypofractionated Radiotherapy Produce Similar Outcomes in Breast Cancer
New research suggests that hypofractionated radiotherapy and conventional fractionated radiotherapy largely produce similar outcomes in patients who have undergone breast cancer surgery.
One-Time Cell Therapy Amtagvi Gets Accelerated Approval for Advanced Melanoma
Amtagvi is a tumor-derived autologous T cell immunotherapy designed to deploy patient-specific T cells called TIL cells to locate and attack cancer cells.
Risk Stratification Can Predict Outcomes for CAR T-Cell Therapy in Lymphoma
Stratification based on prelymphodepletion C-reactive protein, ferritin can classify patients into high, intermediate, and low risk.
Lack of Nurse Education on Genomics a Barrier to Its Use in Clinical Practice
A study comprising of a survey and focus group discussions identified barriers to nurse education and use of genomic information in nursing clinical practice.
Pegargiminase Confers Survival Benefit in Nonepithelioid Pleural Mesothelioma
Adding pegargiminase to standard chemotherapy can improve outcomes in patients with chemotherapy-naïve, nonepithelioid pleural mesothelioma, data suggest.
Alpelisib May Cause Diabetic Ketoacidosis in Patients With Breast Cancer
Patients receiving alpelisib for advanced breast cancer may be at risk of developing diabetic ketoacidosis, data suggest.
Brain Cancer Risk Increased After Moderate/Severe, Penetrating TBI
Risk for subsequent development of brain cancer increased in cohort of mostly male veterans.
ChatGPT Responses to Immuno-Oncology Questions Are Readable and Reproducible
This cross-sectional study assessed the feasibility of using AI-based large language models for education and management information for patients with cancer and healthcare providers.
Impact of Hormone Therapy on Cognition in Prostate Cancer Still Unclear
There is no consensus on how hormone therapy impacts cognition in patients with prostate cancer, according to researchers.
- Loading...
